0001127602-22-003422.txt : 20220204
0001127602-22-003422.hdr.sgml : 20220204
20220204171207
ACCESSION NUMBER: 0001127602-22-003422
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220202
FILED AS OF DATE: 20220204
DATE AS OF CHANGE: 20220204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CONCANNON BRIAN
CENTRAL INDEX KEY: 0001261784
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39218
FILM NUMBER: 22594542
MAIL ADDRESS:
STREET 1: HAEMONETICS CORP
STREET 2: 400 WOOD RD
CITY: BRAINTREE
STATE: MA
ZIP: 02184-9144
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONMED Corp
CENTRAL INDEX KEY: 0000816956
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 160977505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11311 CONCEPT BOULEVARD
CITY: LARGO
STATE: FL
ZIP: 33773
BUSINESS PHONE: 727-214-2974
MAIL ADDRESS:
STREET 1: 11311 CONCEPT BOULEVARD
CITY: LARGO
STATE: FL
ZIP: 33773
FORMER COMPANY:
FORMER CONFORMED NAME: CONMED CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-02
0000816956
CONMED Corp
CNMD
0001261784
CONCANNON BRIAN
C/O CONMED CORPORATION
11311 CONCEPT BOULEVARD
LARGO
FL
33773
1
Common Stock
2022-02-02
4
S
0
2027
135.09
D
13400
D
Common Stock
2022-02-02
4
S
0
4200
136.96
D
9200
D
Common Stock
2022-02-02
4
S
0
200
137.91
D
9000
D
Common Stock
2022-02-02
4
M
0
2549
69.03
A
11549
D
Common Stock
2022-02-02
4
S
0
2549
135.08
D
9000
D
Common Stock
2022-02-02
4
M
0
2165
79.94
A
11165
D
Common Stock
2022-02-02
4
S
0
2165
135.08
D
9000
D
Common Stock
2022-02-02
4
M
0
1843
73.94
A
10843
D
Common Stock
2022-02-02
4
S
0
1843
135.06
D
9000
D
Common Stock
2022-02-02
4
M
0
1000
33.43
A
10000
D
Common Stock
2022-02-02
4
F
0
241
139.03
D
9759
D
Common Stock
2022-02-02
4
M
0
1000
39.64
A
10759
D
Common Stock
2022-02-02
4
F
0
286
139.03
D
10473
D
Common Stock
2022-02-02
4
M
0
1000
55.70
A
11473
D
Common Stock
2022-02-02
4
F
0
401
139.03
D
11072
D
Options To Purchase Common Stock
69.03
2022-02-02
4
M
0
2549
0
D
2019-06-01
2028-06-01
Common Stock
2549
0
D
Options To Purchase Common Stock
79.94
2022-02-02
4
M
0
2165
0
D
2020-06-01
2029-06-03
Common Stock
2165
0
D
Options To Purchase Common Stock
73.94
2022-02-02
4
M
0
1843
0
D
2021-06-01
2030-06-01
Common Stock
1843
0
D
Sars (Stock Appreciation Rights)
33.43
2022-02-02
4
M
0
1000
0
D
2014-06-01
2023-07-26
Common Stock
1000
0
D
Sars (Stock Appreciation Rights)
39.64
2022-02-02
4
M
0
1000
0
D
2015-06-01
2024-09-11
Common Stock
1000
0
D
Sars (Stock Appreciation Rights)
55.70
2022-02-02
4
M
0
1000
0
D
2016-06-01
2025-06-01
Common Stock
1000
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.29 to $137.06. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.88 to $137.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.82. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.84. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.
The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service.
Sarah M. Oliker for Brian Concannon by Power of Attorney
2022-02-03